PIPELINE EMBOLIZATION DEVICE
Report
- Report Number
- 2029214-2014-00504
- Event Type
- Injury
- Date Received
- August 28, 2014
- Date of Event
- August 13, 2014
- Report Date
- August 13, 2014
- Manufacturer
- EV3 NEUROVASCULAR
- Product Code
- OUT
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- PHYSICIAN
Narratives
THE DEVICE INVOLVED IN THE EVENT WILL NOT BE RETURNED FOR EVAL AS IT WAS IMPLANTED IN THE PT. (B)(4).
(B)(4)
TREATMENT OF AN UNRUPTURED BI-LOBED RIGHT SUPERIOR HYPOPHYSEAL ARTERY ANEURYSM MEASURING 6MM. ON (B)(6) 2014, THE PT UNDERWENT PIPELINE EMBOLIZATION TREATMENT INVOLVING TWO PIPELINES. THE PT WAS GIVEN DUAL ANTIPLATELET THERAPY (ASPIRIN AND PLAVIX) AND HEPARIN ACCORDING TO PROTOCOL. DURING THE PROCEDURE, IT WAS REPORTED THE FIRST PIPELINE (4MM X 16MM) WAS NOT OPENING PROPERLY UNDER FLUOROSCOPY DESPITE ADVANCED DEPLOYMENT TECHNIQUES. THE PIPELINE WAS REMOVED FROM THE PT BY TRAPPING THE PIPELINE BRAID BETWEEN THE CAPTURE COIL AND THE CATHETER. ANOTHER PIPELINE (4MM X 16MM) WAS IMPLANTED IN THE PT WITHOUT ISSUES. ON (B)(6) 2013, THE PT SUFFERED AN INTRACRANIAL HEMORRHAGE IN THE RIGHT BASAL GANGLIA, TEMPORAL, AND FRONTAL LOBES AND THE PT WAS REPORTED TO BE IN THE HOSPITAL. THE CAUSE OF THE HEMORRHAGE WAS UNK, BUT IT WAS LIKELY NOT AN ANEURYSM RUPTURE. IT WAS NOTICED BY THE PHYSICIAN THAT A HEMATOMA EVAL WAS PERFORMED. ON (B)(6) 2014, THE PT WAS REPORTED TO BE IN POOR CONDITION. THE PT WAS ALERT AND FOLLOWED SIMPLE COMMANDS WITH A DYSCONJUGATE GAZE AND GAZE PREFERENCE TO THE LEFT. THE PT HAD RIGHT SIDE SPONTANEOUS MOVEMENT AGAINST GRAVITY WITH EXTENDS ON LUE (LEFT UPPER EXTREMITIES) AND TRIPLE FLEX ON LLE (LOWER LEFT EXTREMITIES). SAME EVENT AS MDR # 2029214-2014-00503.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 523979 | PIPELINE EMBOLIZATION DEVICE | FLOW DIVERSION, PRODUCT CODE: OUT | OUT | EV3 NEUROVASCULAR | FA-77400-16 | 9944370 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 42 YR | Required Intervention| S |